| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,850 | 6,020 | 18.11. | |
| 5,900 | 5,980 | 18.11. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.09. | Riber's first-half revenue grows 19% year-on-year to €12.7m | 6 | Semiconductor Today | ||
| 24.09. | Riber Reports Improved Results For The First Half Of 2026 | 609 | GlobeNewswire (Europe) | RIBER REPORTS IMPROVED RESULTS FOR THE FIRST HALF OF 2026 Revenues of €12.7m (+19%) and gross margin of €5.1m (+31%), representing 39.8% of revenuesPositive net income of €0.2m, compared with -€0.8m... ► Artikel lesen | |
| 22.07. | Riber's revenue grows 19% in first-half 2026, driven by 71% growth in Services & Accessories | 7 | Semiconductor Today | ||
| 22.07. | Riber: First-Half 2026 Business Activity: Business Growth, Resilient Order Book And Continued Rollout Of Rosie | 1.292 | GlobeNewswire (Europe) | FIRST-HALF 2026 BUSINESS ACTIVITYBusiness growth, resilient order book and continued rollout of ROSIE Bezons, July 22, 2026 - 8:00 am - RIBER, the global leader in molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
| 10.07. | Riber receives new order from 3SP for production platform | 2 | Semiconductor Today | ||
| 09.07. | RIBER receives a new order from 3SP Technologies for a production platform | 1.336 | GlobeNewswire (Europe) | RIBER receives a new order from 3SP Technologies for a production platform Bezons (France), July 9, 2026 - 8:00 am (CET) - RIBER, a global market leader in molecular beam epitaxy (MBE) equipment for... ► Artikel lesen | |
| 19.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 19.06.2026 | 1.807 | Xetra Newsboard | Das Instrument 5DP NO0013711739 DOLPHIN DRILL.A.S. NK 2,5 EQUITY wird ex Kapitalmassnahme gehandelt am 19.06.2026 The instrument 5DP NO0013711739 DOLPHIN DRILL.A.S. NK 2,5 EQUITY is traded ex capital... ► Artikel lesen | |
| 17.06. | Riber: Annual General Meeting of June 17, 2026: RIBER confirms the execution of its technology roadmap and accelerates with ROSIE | 1.297 | GlobeNewswire (Europe) | Annual General Meeting of June 17, 2026: RIBER confirms the execution of its technology roadmap and accelerates with ROSIE Bezons, June 17, 2026 - 5:45 p.m. - RIBER, the global leader in molecular... ► Artikel lesen | |
| RIBER Aktie jetzt für 0€ handeln | |||||
| 09.04. | Riber: Margen steigen, KI-Boom treibt - Hidden Champion vor nächsten Kursschub? | 1.752 | ARIVA.de | Hightech "Made in France" mit Rückenwind durch KI und Photoniks: Riber verbessert trotz leicht rückläufigem Umsatz deutlich seine Profitabilität und könnte vor einem neuen Wachstumszyklus stehen. Riber... ► Artikel lesen | |
| 08.04. | RIBER delivers strong earnings growth in 2025 | 1.382 | GlobeNewswire (Europe) | RIBER delivers strong earnings growth in 2025 Revenues: €40.3m (-2%)Income from ordinary operations: €5.1m, representing 13% of revenues Net income: €5.2m (+27%)Proposed payout of €0.10 per share... ► Artikel lesen | |
| 02.02. | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 1.305 | GlobeNewswire (Europe) | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| 19.01. | Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom | 1.183 | GlobeNewswire (Europe) | Riber receives a new order from Japan for MBE 6000 to scale Quantum Dot Laser production for Datacom. Bezons (France), 19 January 2026 - 8:00 am (CET) - RIBER, a global market leader in molecular beam... ► Artikel lesen | |
| 29.12.25 | RIBER receives a major order in Europe for two MBE 6000 production systems, including associated services | 1.615 | GlobeNewswire (Europe) | RIBER receives a major order in Europe for two MBE 6000 production systems, including associated services Bezons (France), December 29, 2025 - 8:00 am - RIBER, a global market leader in molecular... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 14,500 | -3,97 % | EQS-News: Formycon AG: Formycon verdoppelt Neunmonatsumsatz und treibt Umsetzung der Wachstumsstrategie FYB4Growth konsequent voran | EQS-News: Formycon AG
/ Schlagwort(e): 9-Monatszahlen
Formycon verdoppelt Neunmonatsumsatz und treibt Umsetzung der Wachstumsstrategie FYB4Growth konsequent voran
12.11.2026... ► Artikel lesen | |
| SOLESENCE | 1,640 | 0,00 % | Solesence expects at least $65M in shipped and on-hand orders by year-end, while pointing to potential >20% EBITDA longer term | ||
| KOPIN | 2,749 | +1,44 % | Stifel bekräftigt Kaufempfehlung für Kopin nach starkem Quartalsergebnis | ||
| ONTO INNOVATION | 189,20 | +3,33 % | Onto Innovation Inc.: Onto Innovation to Participate in Upcoming Investor Events | Onto Innovation Inc. (NYSE: ONTO) ("Onto Innovation," "Onto," or the "Company") today announced that its senior management team will participate in the following upcoming investor events:
RBC... ► Artikel lesen | |
| GAUZY | 4,770 | -5,36 % | GAUZY LTD: Gauzy Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal | TEL AVIV, Israel, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced receipt of a delisting... ► Artikel lesen | |
| OBDUCAT | 0,033 | +26,92 % | NGM MARKET NOTICE: #26-72 Decision by the Disciplinary Committee regarding Obducat AB (publ) | ||
| GOMSPACE | 1,225 | -1,13 % | GomSpace Group AB: GomSpace reports continued profitable growth in Q3 and narrows full year guidance | GomSpace reports continued profitable growth in Q3 and narrows full year guidance
GomSpace delivers revenue growth with a 14% EBITDA margin in Q3 and sets 2030 financial targets of SEK 1.6 billion... ► Artikel lesen | |
| DOTZ NANO | 0,005 | -16,67 % | XFRA 57N: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| NANOFORM FINLAND | 0,773 | -2,64 % | Nanoform Finland Oyj: Nanoform Q2 2026 - Positive feedback from scientific advice meeting in the UK, significantly improved cash flow and discussions with CDMOs on sterile GMP for our Biologics technology initiated | Nanoform Finland Plc | Company Release | August 20, 2026 at 08:10:00 EEST
Nanoenzalutamide project continues with the communicated multitrack strategy supported by all partners. After a positive scientific... ► Artikel lesen | |
| VEECO INSTRUMENTS | 34,060 | 0,00 % | Veeco Instruments Inc.: Veeco Announces Upcoming Investor Events | ||
| ACACIA RESEARCH | 3,620 | -1,09 % | ACACIA RESEARCH CORP - 10-K/A, Annual Report | ||
| NVE | 71,50 | 0,00 % | Dividendenbekanntmachungen (02.11.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABM INDUSTRIES INC US0009571003 0,29 USD EUR ACUITY INC US00508Y1029 0,2 USD EUR AMERISERV FINANCIAL INC US03074A1025 0,03... ► Artikel lesen | |
| ADVANCE ZINCTEK | 0,298 | -0,67 % | ADVANCE ZINCTEK LIMITED: Proposed Capital Reduction of 3 Cents | ||
| LAMPETIA | 0,105 | 0,00 % | EQS-Adhoc: Lampetia AG: Verkauf der Lampetia Investments Engineering Ltd geplant | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Mergers und Acquisitions / Verkauf von Unternehmensteilen
Lampetia AG: Verkauf der Lampetia Investments Engineering Ltd geplant
06.11.2026... ► Artikel lesen | |
| NANOVIRICIDES | 1,060 | +1,92 % | NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox | SHELTON, CT / ACCESS Newswire / November 17, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ending... ► Artikel lesen |